Skip to main content Accesibility Help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article
  • Cited by 17
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Jafari, Mehdi Mousavi, Seyed Masood Asgharzadeh, Asra and Yazdani, Neda 2018. Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews. Indian Heart Journal, Vol. 70, Issue. , p. S111.
    Chen, Fong-Lin Chang, Po-Sheng Lin, Yi-Chin and Lin, Ping-Ting 2018. A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy. Nutrients, Vol. 10, Issue. 11, p. 1697.
    Lei, Li and Liu, Yan 2017. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovascular Disorders, Vol. 17, Issue. 1,
    Yan, Bingju Sun, Yingxian and Wang, Jun 2017. Depletion of ubiA prenyltransferase domain containing 1 expression promotes angiotensin II-induced hypertrophic response in AC16 human myocardial cells via modulating the expression levels of coenzyme Q10 and endothelial nitric oxide synthase. Molecular Medicine Reports, Vol. 16, Issue. 5, p. 6910.
    Stojanović, Marko and Radenković, Miroslav 2017. A meta-analysis of randomized and placebo-controlled clinical trials suggests that coenzyme Q10 at low dose improves glucose and HbA1c levels. Nutrition Research, Vol. 38, Issue. , p. 1.
    Oleck, Sylvia and Ventura, Hector O. 2016. Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?. Current Heart Failure Reports, Vol. 13, Issue. 4, p. 190.
    McQueen, Cydney E. and Orr, Katherine Kelly 2015. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 18th Edition.
    Donnino, Michael W. Mortensen, Sharri J. Andersen, Lars W. Chase, Maureen Berg, Katherine M. Balkema, Julia Radhakrishnan, Jeejabai Gazmuri, Raúl J. Liu, Xiaowen and Cocchi, Michael N. 2015. Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial. Critical Care, Vol. 19, Issue. 1,
    Ayer, Anita Macdonald, Peter and Stocker, Roland 2015. CoQ10 Function and Role in Heart Failure and Ischemic Heart Disease. Annual Review of Nutrition, Vol. 35, Issue. 1, p. 175.
    Kornfeld, Opher S. Hwang, Sunhee Disatnik, Marie-Hélène Chen, Che-Hong Qvit, Nir and Mochly-Rosen, Daria 2015. Mitochondrial Reactive Oxygen Species at the Heart of the Matter. Circulation Research, Vol. 116, Issue. 11, p. 1783.
    Zahedi, Hoda Eghtesadi, Shahryar Seifirad, Soroush Rezaee, Neshat Shidfar, Farzad Heydari, Iraj Golestan, Banafsheh and Jazayeri, Shima 2014. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial. Journal of Diabetes & Metabolic Disorders, Vol. 13, Issue. 1,
    Baruteau, J. Hargreaves, I. Krywawych, S. Chalasani, A. Land, J.M. Davison, J.E. Kwok, M.K. Christov, G. Karimova, A. Ashworth, M. Anderson, G. Prunty, H. Rahman, S. and Grünewald, S. 2014. Successful reversal of propionic acidaemia associated cardiomyopathy: Evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism. Mitochondrion, Vol. 17, Issue. , p. 150.
    Pagano, Giovanni Aiello Talamanca, Annarita Castello, Giuseppe Cordero, Mario d'Ischia, Marco Gadaleta, Maria Pallardó, Federico Petrović, Sandra Tiano, Luca and Zatterale, Adriana 2014. Current Experience in Testing Mitochondrial Nutrients in Disorders Featuring Oxidative Stress and Mitochondrial Dysfunction: Rational Design of Chemoprevention Trials. International Journal of Molecular Sciences, Vol. 15, Issue. 11, p. 20169.
    Madmani, Mohammed E Yusuf Solaiman, Ahmad Tamr Agha, Khalil Madmani, Yasser Shahrour, Yasser Essali, Adib and Kadro, Waleed 2014. Coenzyme Q10 for heart failure. Cochrane Database of Systematic Reviews,
    Turk, Suleyman Baki, Aysegul Solak, Yalcin Kayrak, Mehmet Atalay, Huseyin Gaipov, Abduzhappar Aribas, Alpay Akilli, Hakan Biyik, Zeynep Okudan, Nilsel and Gokbel, Hakki 2013. Coenzyme Q10 supplementation and diastolic heart functions in hemodialysis patients: A randomized double-blind placebo-controlled trial. Hemodialysis International, Vol. 17, Issue. 3, p. 374.
    Mischley, Laurie K. Allen, Jason and Murray, Michael T. 2013. Textbook of Natural Medicine. p. 675.
    Karakukcu, Cigdem Karakukcu, Musa Unal, Ekrem Patiroglu, Turkan Ozdemir, Mehmet A. Torun, Yasemin A. and Tang, Peter H. 2012. Coenzyme Q10Levels in β-Thalassemia and its Association with Ferritin Levels and Chelation Therapy. Hemoglobin, Vol. 36, Issue. 3, p. 219.
    ×
  • Get access
    Add to cart USD35.00
    Check if you have access via personal or institutional login
    Log in Register

Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy

  • Armen Kocharian (a1), Reza Shabanian (a1), Mohammad Rafiei-Khorgami (a1), Abdolrazagh Kiani (a1) and Giv Heidari-Bateni (a1)...
Abstract

We aimed to determine the effect of supplementation with coenzyme Q10 on conventional therapy of children with cardiac failure due to idiopathic dilated cardiomyopathy. In a prospective, randomized, double-blinded, placebo-controlled trial, we randomized 38 patients younger than 18 years with idiopathic dilated cardiomyopathy to receive either coenzyme Q10, chosen for 17 patients, or placebo, administered in the remaining 21. Echocardiographic systolic and diastolic function parameters were determined for every patient at baseline, and after 6 months of supplementation. The index score for cardiac failure in children as established in New York was used for assessing the functional class of the patients. After 6 months supplementation, 10 patients randomized to receive coenzyme Q10 showed improvements in the grading of diastolic function, this being significantly more than that achieved by those randomized to the placebo group (p value = 0.011). The mean score for the index of cardiac failure index for those receiving coenzyme Q10 was also lower than the control group (p value = 0.024).

Our results, therefore, indicate that administration of coenzyme Q10 is useful in ameliorating cardiac failure in patients with idiopathic dilated cardiomyopathy through its significant effect on improving diastolic function.

Copyright
COPYRIGHT: © Cambridge University Press 2009
Corresponding author
Correspondence to: Giv Heidari-Bateni, MD/MPH, General Practitioner, Children’s Medical Center, 62 Gharib Street, 14194, Tehran, Iran. Tel: +98 2166507851; Fax: +98 21 66930024; E-mail: givhb@yahoo.com
References
Hide All
1. Hadj, A, Pepe, S, Rosenfeldt, F. The clinical application of metabolic therapy for cardiovascular disease. Heart Lung Circ 2007; 16 (Suppl): S56–S64.
2. Singh, U, Devaraj, S, Jialal, I. Coenzyme Q10 supplementation and heart failure. Nutr Rev 2007; 65: 286–293.
3. Bhagavan, HN, Chopra, RK. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy. Clin Nutr 2005; 24: 331–338.
4. Langsjoen, PH, Vadhanavikit, S, Folkers, K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme 10. Proc Natl Acad Sci 1985; 82: 4240–4244.
5. Poggesi, L, Galanti, G, Comeglio, M, Toncelli, L, Vinci, M. Effect of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy. Current Therapeutic Research 1991; 49: 878–886.
6. Permanetter, B, Rossy, W, Klein, G, Weingartner, F, Seidl, KF, Blomer, H. Ubiquinone (coenzyme q10) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13: 1528–1533.
7. Munkholm, H, Hansen, HHT, Rasmussen, K. Coenzyme Q10 treatment in serious heart failure. BioFactors 1999; 9: 285–289.
8. Watson, PS, Scalia, GM, Galbraith, A, Burstow, DJ, Bett, N, Aroney, CN. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Card 1999; 33: 1549–1552.
9. Keogh, A, Fenton, S, Leslie, C, et al. Randomized double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure. Heart Lung Circ 2003; 12: 135–141.
10. Elshershari, H, Ozer, S, Ozkutlu, S, Ozme, S. Potential usefulness of coenzyme Q10 in the treatment of idiopathic dilated cardomyopathy in children. Int J Cardiol 2003; 88: 101–102.
11. Soongswang, J, Sangtawesin, C, Durongpisitkul, K, et al. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Pediatr Cardiol 2005; 26: 361–366.
12. Richardson, P, McKenna, W, Bristow, M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841–842.
13. Connolly, D, Rutkowski, M, Auslender, M, Artman, M. The New York University Pediatric Heart Failure Index: A new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644–648.
14. O’Leary, PW. Pediatric diastology: use and limitations of Doppler echocardiography in the evaluation of ventricular diastolic function in children. Prog Pediatr Cardiol 1999; 10: 83–93.
15. O’Leary, PW, Durongpisitkul, K, Cordes, TM, et al. Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. Mayo Clin Proc 1998; 73: 616–628.
16. Tei, C, Ling, LH, Hodge, DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function – a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357–366.
17. Colan, SD, Parness, IA, Spevak, PJ, Sanders, SP. Developmental modulation of myocardial mechanics: age and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992; 19: 619–629.
18. Tissières, P, Aggoun, Y, Da Cruz, E, et al. Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatr 2006; 149: 210–215.
19. Little, WC, Cheng, C-P. Diastolic dysfunction. Cardiol Rev 1998; 6: 231–239.
20. Vivekananthan, K, Kalapura, T, Mehra, M, et al. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol 2002; 90: 517–520.
21. Peltier, M, Slama, M, Garbi, S, Enriquez-Sarano, ML, Goissen, T, Tribouilloy, CM. Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction. Am J Cardiol 2002; 90: 1261–1263.
22. Redfield, MM, Jacobsen, SJ, JrBurnett, JC, Mahoney, DW, Bailey, KR, Rodeheffer, RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194–202.
23. Fischer, M, Baessler, A, Hense, HW, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24: 320–328.
24. Zile, MR, Brutsaert, DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002; 105: 1503–1508.
25. Auslender, M. Pathophysiology of pediatric heart failure. Prog Pediatr Cardiol 2002; 11: 175–184.
26. Bhagavan, HN, Chopra, RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006; 40: 445–453.
27. Silver, MA, Langsjoen, PH, Szabo, S, Patil, H, Zelinger, A. Effect of Atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. Am J Cardiol 2004; 94: 1306–1310.
28. Langsjoen, PH, Langsjoen, PH, Folkers, K. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment. Clin Invest 1993; 71 (Suppl): S140–S144.
29. Oda, T. Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: echocardiographic study. Mol Aspects Med 1994; 15 (Suppl): S149–S154.
30. Lönnrot, K, Pörsti, I, Alho, H, Wu, X, Hervonen, A, Tolvanen, JP. Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats. Br J Pharmacol 1998; 124: 1500–1506.
31. Belardinelli, R, Tiano, L, Littarru, GP. Oxidative stress, endothelial function and coenzyme Q10. Biofactors 2008; 32: 129–133.
32. Tiano, L, Belardinelli, R, Carnevali, P, Principi, F, Seddaiu, G, Littarru, GP. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007; 28: 2249–2255.
33. Grodecki, PV, Klein, AL. Pitfalls in the echo-Doppler assessment of diastolic dysfunction. Echocardiography 1993; 10: 213–234.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Cardiology in the Young
  • ISSN: 1047-9511
  • EISSN: 1467-1107
  • URL: /core/journals/cardiology-in-the-young
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Cancel
Confirm
×